Newsroom

New START early-phase clinical trial site brings advanced cancer research to Northwell’s Cancer Institute New Hyde Park, NY / San Antonio, TX – May 31, 2024.  Northwell Health, New York State’s largest health care provider, and The START Center for Cancer Research (“START”), renowned for being the largest global network of fully dedicated, community-based, early-phase […]

The START Center for Cancer Research (“START”) is set to have a significant presence at the American Society of Clinical Oncology (ASCO) 2024 Annual Meeting. Known for our commitment to the advancement of cancer research and treatment, we are excited to share that our team of Principal Investigators (PIs) will be involved in nearly 100

New CEO Nick Slack selected to lead the organization in its next phase of growth SAN ANTONIO–(BUSINESS WIRE)–The START Center for Cancer Research, the world’s largest global site network of early phase oncology clinical trials, sets its sights on expanding access to breakthrough research to all communities globally. Currently running one of the largest portfolios

2022 ESMO IMMUNO-ONCOLOGY (ESMO IO) ACTIVITY SUMMARY The START Center investigators contributed as authors to posters and abstracts at this year’s ESMO IO meeting in Geneva, Switzerland. Congratulations to the START physician team, Dr. Kyriakos Papadopoulos, Dr. Nehal Lakhani, Dr. Manish Sharma, Dr. Amita Patnaik, Dr. Drew Rasco, and Dr. Victor Moreno, for their contributions

Download Announcement ALAMEDA, Calif.–(BUSINESS WIRE)–Dec. 8, 2022– Exelixis, Inc. (Nasdaq: EXEL) today announced initial results from the ongoing dose-escalation stage of QUARTZ-101, a phase 1 clinical trial evaluating XL102, a potent, selective, irreversible and orally bioavailable small molecule cyclindependent kinase 7 (CDK7) inhibitor, in patients with advanced solid tumors. The data are being presented on

First oncology early-phase clinical trials units in Portugal and Ireland to offer leading-edge cancer treatments –(BUSINESS WIRE)– SAN ANTONIO–(BUSINESS WIRE)–The START Center for Cancer Care, a San Antonio-based oncology early-phase clinical research site network, will open Portugal’s first facility in Lisbon in late 2022 and is slated to open Ireland’s first early-phase clinical research facility

First oncology early phase clinical trials unit in Portugal to offer leading-edge cancer treatments SAN ANTONIO, Aug. 16, 2022 – The START Center for Cancer Care, a San Antonio-based oncology early-phase clinical research site network, will open Portugal’s first facility in Lisbon in late 2022. START Center’s agreement with Hospital de Santa Maria – Centro